Search Results - Luis Manso

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain by Luis Paz-Ares, Luis Manso, Guillermo De Velasco

    Published in ESMO Open (2020-05-01)
    Get full text
    Article


  2. 2

    Special Issue “Cognitive Robotics” by Antonio Bandera, Luis Manso Fernández-Argüéllez, Zoe Falomir

    Published in Applied Sciences (2022-09-01)
    Get full text
    Article


  3. 3

    Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice by Ignacio Romero, Eva Guerra, Ainhoa Madariaga, Luis Manso

    Published in Frontiers in Oncology (2024-01-01)
    Get full text
    Article


  4. 4

    The Erosion of the Portuguese Minimum Income Protection Scheme by Luis Manso, Renato Miguel Carmo, Maria Clara Oliveira, Jorge Caleiras

    Published in Social Inclusion (2025-07-01)
    Get full text
    Article


  5. 5

    Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report by Macarena Rey-Cárdenas, Lucia Parrilla-Rubio, Luis Manso, Rodrigo Sanchez-Bayona, Carmen Alvarez-Conejo, Ainhoa Madariaga

    Published in Gynecologic Oncology Reports (2023-10-01)
    Get full text
    Article


  6. 6

    FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1 by Silvana Mouron, Luis Manso, Eduardo Caleiras, Jose L. Rodriguez-Peralto, Oscar M. Rueda, Carlos Caldas, Ramon Colomer, Miguel Quintela-Fandino, Maria J. Bueno

    Published in Breast Cancer Research (2021-02-01)
    Get full text
    Article


  7. 7

    Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program by Alfonso Yubero, Purificación Estévez, Aránzazu Barquín, Luisa Sánchez, Ana Santaballa, Bella Pajares, Piedad Reche, Carmen Salvador, Luis Manso, Raúl Márquez, Antonio González-Martín

    Published in Gynecologic Oncology Reports (2023-08-01)
    Get full text
    Article


  8. 8

    Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis by Alberto Carretero-González, Marta Hergueta-Redondo, Sara Sánchez-Redondo, Pilar Ximénez-Embún, Luis Manso Sánchez, Eva Ciruelos Gil, Daniel Castellano, Guillermo de Velasco, Héctor Peinado

    Published in OncoImmunology (2022-12-01)
    Get full text
    Article


  9. 9

    Management of advanced ovarian cancer in Spain: an expert Delphi consensus by Andres Redondo, Ana Oaknin, Maria Jesus Rubio, Maria-Pilar Barretina-Ginesta, Ana de Juan, Luis Manso, Ignacio Romero, Cristina Martin-Lorente, Andres Poveda, Antonio Gonzalez-Martin

    Published in Journal of Ovarian Research (2021-05-01)
    Get full text
    Article


  10. 10

    Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance. by Luis Manso, Silvana Mourón, Michael Tress, Gonzalo Gómez-López, Manuel Morente, Eva Ciruelos, Miriam Rubio-Camarillo, Jose Luis Rodriguez-Peralto, Miguel A Pujana, David G Pisano, Miguel Quintela-Fandino

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  11. 11

    582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1... by Kevin Kelly, Matt Coffey, Tomás Pascual, Aleix Prat, Luis Manso, Thomas Heineman, Fernando Salvador, Joaquín Gavilá, Houra Loghmani, Richard Trauger, Akil Merchant, Julian Olea, Homa Dadrastoussi, Eduardo Fernandez Hernandez, Hugo Lara Martinez, Kaijin Wu

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  12. 12

    Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study by Alfonso Yubero, Aranzazu Barquín, Purificación Estévez, Bella Pajares, Luisa Sánchez, Piedad Reche, Jesús Alarcón, Julia Calzas, Lydia Gaba, José Fuentes, Ana Santaballa, Carmen Salvador, Luis Manso, Ana Herrero, Álvaro Taus, Raúl Márquez, Julia Madani, María Merino, Gloria Marquina, Victoria Casado, Manuel Constenla, María Gutiérrez, Alba Dosil, Antonio González-Martín

    Published in BMC Cancer (2022-11-01)
    Get full text
    Article


  13. 13

    Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade by Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Olga Martínez, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R. Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat

    Published in Nature Communications (2020-01-01)
    Get full text
    Article


  14. 14

    Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer by Whitney S Graybill, Ignace Vergote, Bhavana Pothuri, Maarit Anttila, David M O’Malley, Domenica Lorusso, Ashley F Haggerty, Michel Fabbro, John K Chan, Florian Heitz, Lyndsay J Willmott, Ilan Bruchim, Ying Zhuo, Purificacion Estevez-Garcia, Bradley J Monk, Hannelore Denys, Anja Knudsen, Anna V Tinker, Luis Manso Sanchez, Diane Provencher, Maria Pilar Barretina-Ginesta, John Hartman, Donna V Booth, Antonio Gonzalez-Martin

    Article


  15. 15

    HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab by Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, Elia Seguí, Esther Carcelero, Pablo Tolosa, Jesús Soberino, Manuel Alva, Tomás Pascual, Laura Lema, Isabel Garcia-Fructuoso, Maria Angeles Cobos-Fernandez, Maria Rey, Luis Manso, Angela Aguirre, Ainhoa Madariaga, Valeria Sirenko, Cristina González-Deza, Paula Blasco, Astrid Mayhua, Oleguer Castillo, Patricia Galván, Esther Sanfeliu, Guillermo Villacampa, Wesley Buckingham, Mercedes Marín-Aguilera, Laia Paré, Patricia Villagrasa, Charles M. Perou, Julia Maues, Fara Brasó-Maristany, Eva Ciruelos, Aleix Prat

    Published in npj Breast Cancer (2025-04-01)
    Get full text
    Article


Search Tools: